Marchward Marchward
Home Articles -Corrections -Digests -Essays -Reports -Updates Authors Sign In Sign Up
Sign In Sign Up
Digest №1: A Way to Serve Your Outliving Cancer Better and Consideration with Anti-Cancer Ketogenic Diet
Image by Andrei Ciubotariu.

Digest №1: A Way to Serve Your Outliving Cancer Better and Consideration with Anti-Cancer Ketogenic Diet

2026, week 8: Ketogenic diets are powerful but imperfect anti-cancer tools, alkalisation shows anti-cancer efficacy in human patients.

Digests

Merlin L. Marquard

Merlin L. Marquard

Feb 23, 2026 — 4 min read
On the Gamification of Cancer Survival
Photo by Mohamed Nohassi / Unsplash

On the Gamification of Cancer Survival

A cancer diagnosis is one of the most daunting and stressful events in a cancer patient's life. So, how can we frame this challenge to make it a bit less stressful and dire?

Essays

Merlin L. Marquard

Merlin L. Marquard

Feb 14, 2026 — 6 min read
In Defence of Classical Care and Classically Trained Physicians and Nurses
Photo by SJ Objio / Unsplashpe

In Defence of Classical Care and Classically Trained Physicians and Nurses

The limitations of classical care in no way are a condemnation of it. Much more their understanding can enable us to use classical care more effectively and with less frustration.

Essays

Merlin L. Marquard

Merlin L. Marquard

Feb 11, 2026 — 3 min read
Anecdotal Success in Using a Soft Pharmaceutical Regimen to Lower the IL-6 Status in a Patient with Malignant Pleural Mesothelioma
Photo by Immo Wegmann / Unsplash

Anecdotal Success in Using a Soft Pharmaceutical Regimen to Lower the IL-6 Status in a Patient with Malignant Pleural Mesothelioma

4 months of treatment with a pharmaceutical plan formulated to suppress IL-6 over-expression in one patient has shown first success. Continuation and reproducibility of the effect remain to be seen.

Reports

Merlin L. Marquard

Merlin L. Marquard

Feb 5, 2026 — 5 min read
Correction: Ganoderma Lucidum Suppresses IL-6 only Inconsistently with Variance between Experiments
Photo by Randy Laybourne / Unsplash

Correction: Ganoderma Lucidum Suppresses IL-6 only Inconsistently with Variance between Experiments

In a prior article, information about discrepancies in the effect of Ganoderma lucidum on IL-6 profiles. This is a correction to that article.

Corrections

Merlin L. Marquard

Merlin L. Marquard

Jan 23, 2026 — 2 min read
On The Therapeutic Potential of Tocilizumab in IL-6-Positive Cancers
Photo by ANIRUDH / Unsplash

On The Therapeutic Potential of Tocilizumab in IL-6-Positive Cancers

IL-6 is an immune signaller misappropriated by many cancer types to engender immune senescence and proliferative auto-signalling. Disrupting this misappropriation can help overcome IL-6-positive cancers.

Essays

Merlin L. Marquard

Merlin L. Marquard

Jan 17, 2026 — 4 min read
Dandelions: Just Pretty Flowers or Anti-Cancer Powerhouses?
Photo by Viridi Green / Unsplash

Dandelions: Just Pretty Flowers or Anti-Cancer Powerhouses?

Dandelions have been used for centuries, if not millennia in traditional German medicine, but recent research indicates that they may have potent activity against that most insidious of diseases – cancer.

Essays

Merlin L. Marquard

Merlin L. Marquard

Jan 15, 2026 — 22 min read
On the Limitations of Standard-of-Care and the Potential of Integrative Therapy
Photo by Myriam Zilles on Unsplas

On the Limitations of Standard-of-Care and the Potential of Integrative Therapy

Standard-of-care for most cancers has remained largely stagnant and is commonly faced with the issues of severe side effects and recurrence. A holistic approach to integrative therapy can be used to make up for these shortcomings.

Essays

Cedric L. Marquard

Cedric L. Marquard

Jan 3, 2026 — 15 min read

End of content

Marchward Marchward

Freedom from Cancer

Marchward © 2024 by L. Marquard UG (haftungsbeschränkt) is licensed under CC BY-NC-SA 4.0 CC BY NC SA
Sign up Archive Terms of Service Acceptable Use Policy Disclaimer Privacy Policy Cookie Policy Refund Policy DMCA Policy Impressum Data Subject Access Request Customer Portal